title: Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.
authors.forename: A
authors.initials: A
authors.lastname: Fontanet
authors.forename: Y
authors.initials: Y
authors.lastname: Chalandon
authors.forename: E
authors.initials: E
authors.lastname: Roosnek
authors.forename: B
authors.initials: B
authors.lastname: Mohty
authors.forename: J R
authors.initials: JR
authors.lastname: Passweg
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001792:Blood Platelets / Q000502:physiology; D016022:Case-Control Studies; D005260:Female; D006402:Hematologic Diseases / Q000097:blood / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000502:physiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination